Protection against the neurolathyrism produced by arsanilic acid in the rat.
D006916:5-Hydroxytryptophan / Q000627:therapeutic use; D000818:Animals; D020261:Arsenic Poisoning; D001711:Biotransformation; D003900:Desoxycorticosterone / Q000627:therapeutic use; D005260:Female; D006728:Hormones / Q000627:therapeutic use*; D009069:Movement Disorders / Q000139:chemically induced* / Q000188:drug therapy; D010634:Phenobarbital / Q000494:pharmacology; D010672:Phenytoin / Q000494:pharmacology; D011284:Pregnenolone / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000494:pharmacology; D013256:Steroids / Q000494:pharmacology; D013974:Thyroxine / Q000627:therapeutic use; D014221:Triamcinolone / Q000627:therapeutic use
D006728:Hormones; D013256:Steroids; D014221:Triamcinolone; D012701:Serotonin; D003900:Desoxycorticosterone; D010672:Phenytoin; D011284:Pregnenolone; D006916:5-Hydroxytryptophan; D013974:Thyroxine; D010634:Phenobarbital